🇺🇸 Simivastatin in United States

22 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Headache — 3 reports (13.64%)
  2. Therapy Cessation — 3 reports (13.64%)
  3. Arthritis — 2 reports (9.09%)
  4. Cardiac Disorder — 2 reports (9.09%)
  5. Cardiac Failure — 2 reports (9.09%)
  6. Dyspnoea — 2 reports (9.09%)
  7. Hospitalisation — 2 reports (9.09%)
  8. International Normalised Ratio Increased — 2 reports (9.09%)
  9. Nausea — 2 reports (9.09%)
  10. Unresponsive To Stimuli — 2 reports (9.09%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Simivastatin approved in United States?

Simivastatin does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Simivastatin in United States?

Organon and Co is the originator. The local marketing authorisation holder may differ — check the official source linked above.